FT Vest U.S. Small Cap Moderate Buffer ETF - November (SNOV)
Live price chart, market sentiment, and community perspectives for FT Vest U.S. Small Cap Moderate Buffer ETF - November (CBOE: SNOV).
Live price chart, market sentiment, and community perspectives for FT Vest U.S. Small Cap Moderate Buffer ETF - November (CBOE: SNOV).
On our desk, we are closely tracking the institutional migration out of SNOV. Regulatory filings for Q2 2026 show that 55 hedge funds and large institutions hold about $39.9M, but the breakdown reveals 25 funds reducing exposure and 11 closing positions entirely. The ratio of exits to new entries heavily favors capital contraction, signaling that larger allocators are rethinking their exposure to defined-outcome small-cap buffers as market dynamics shift.
Analyzing the short interest reports for SNOV reveals extreme month-over-month volatility. Short interest jumped by 63.2% to 21,824 shares by mid-July, only to crash by 98.5% down to just 316 shares by mid-August. With an average daily volume around 12,430 shares, the days-to-cover ratio collapsed to virtually zero, indicating that short-term tactical traders completely abandoned their bearish bets in a very short window.
From a quantitative risk management perspective, SNOV's current standing in its outcome period—running from November 24, 2025, to November 20, 2026—presents a unique payoff matrix. With the reference asset (iShares Russell 2000 ETF) returning 27.98% and the fund itself posting a 14.70% return, the remaining net cap sits tightly at 2.46%. An underlying return of -7.47% is all it takes to fully realize the cap, making the risk-reward profile heavily asymmetric for late-stage entrants.
As a portfolio risk manager, I look closely at the buffer mechanics. SNOV was designed with a 15.00% net buffer against initial losses. With roughly 105 days remaining in the outcome period, our data indicates a remaining net buffer of 19.99% and an unrealized net option payoff of 2.46%. While the buffer gives peace of mind, the limited remaining upside cap of 2.46% makes new capital deployment less attractive unless a major correction in small caps occurs before November.
Watching the retail and advisor sentiment boards, SNOV is frequently cited as a defensive vehicle for clients anxious about small-cap volatility. However, the sheer volume of institutional exits in Q2—dropping total capital down to $39.9M across 55 funds—suggests that sophisticated market participants are rotating out of structured buffer wrappers in favor of unhedged equity or different duration instruments as market conditions evolve.
Explore plasma cleansing, somatic organ swaps, and BCI.